Financials in USD. Standardized financial statements.
A compact view of how Novo Nordisk A/S turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $309.06B | $290.40B | $232.26B | $176.95B | $140.80B | $126.95B | $122.02B | $111.83B | $111.70B | $111.78B |
| Revenue Growth? | +6.4% | +25.0% | +31.3% | +25.7% | +10.9% | +4.0% | +9.1% | +0.1% | -0.1% | 0.0% |
| Cost of Revenue? | $58.79B | $44.52B | $35.77B | $28.45B | $23.66B | $20.93B | $20.09B | $17.62B | $17.63B | $17.18B |
| Gross Profit? | $250.28B | $245.88B | $196.50B | $148.51B | $117.14B | $106.01B | $101.93B | $94.21B | $94.06B | $94.60B |
| Gross Margin? | +81.0% | +84.7% | +84.6% | +83.9% | +83.2% | +83.5% | +83.5% | +84.2% | +84.2% | +84.6% |
| Operating Expenses? | $122.62B | $117.54B | $93.92B | $73.70B | $58.50B | $51.89B | $49.45B | $46.97B | $45.10B | $46.16B |
| Operating Income? | $127.66B | $128.34B | $102.57B | $74.81B | $58.64B | $54.13B | $52.48B | $47.25B | $48.97B | $48.43B |
| EBITDA? | $156.73B | $147.94B | $114.63B | $76.80B | $65.39B | $59.27B | $54.43B | $51.63B | $51.95B | $51.06B |
| Income Before Tax | $130.54B | $127.19B | $104.67B | $69.06B | $59.08B | $53.13B | $48.55B | $47.62B | $48.68B | $47.80B |
| Income Tax Expense | $28.11B | $26.20B | $20.99B | $13.54B | $11.32B | $10.99B | $9.60B | $8.99B | $10.55B | $9.87B |
| Net Income? | $102.43B | $100.99B | $83.68B | $55.52B | $47.76B | $42.14B | $38.95B | $38.63B | $38.13B | $37.92B |
| EPS? | $23.06 | $22.67 | $18.67 | $12.26 | $10.40 | $9.03 | $8.21 | $7.98 | $7.71 | $7.50 |
| Diluted EPS? | $23.03 | $22.63 | $18.62 | $12.22 | $10.37 | $9.01 | $8.19 | $7.97 | $7.70 | $7.48 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality